|
|
|
| Connect science and compliance at the 19th annual PDA Pharmaceutical Microbiology Conference, October 7 - 9 in Washington, DC, and navigate the crucial nexus between scientific advancement and regulatory adherence! Don’t miss out on directly interacting with the experts, poster presentations, and the Exhibit Hall where leading companies will showcase the latest technologies, equipment, and applications. This conference sells out quickly! View the agenda and register today. |
|
|
|
|
By Ioanna Deni, BioPlan Associates Inc. | BioPlan Associates' latest manufacturing survey found signs of a maturing market and strong demand for innovation upstream and downstream. |
|
|
|
By Tim Sandle, Ph.D. | ICH Q5A (R2) was released in Nov. 2023 and adopted by the FDA and EMA earlier this year. For a fuller assessment of viral control, compendia from the USP and European Pharmacopeia help. |
|
|
|
By Yadnyesh Patel, microbiology subject matter expert | This article concludes the author's series on bacterial endotoxin testing. It discusses best practices for the labeled lysate sensitivity test, non-interfering dilution determination, and more. |
|
|
|
|
| Understanding Injectable Drug Container Closure Systems | Article | By Louis Brasten, West Pharmaceutical Services, Inc. | Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential. |
|
|
|
|
|
|
|
